chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Insomnia, Lymph node pain, Lymphadenopathy
Clinical narrative: Fatigue; insomnia; Visibly swollen lymph node near collar bone on injection side; Lymph node pain; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies and gastrointestinal issues of undetermined origin. The patient had allergies to food dye, iodine, fenugreek and penicillin. The patient previously took cefalexin (KEFLEX) for unknown indication and experienced drug allergy. Concomitant medications included cetirizine (MANUFACTURER UNKNOWN), 10 mg and vitamins nos  and various supplements  for unknown indications from unknown start dates and unknown if ongoing.  The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 for first 24 hours ,the patient experienced fatigue, followed by insomnia for next 48 hours. On day 2 and 3 after receiving vaccine ,lymph node pain, most pronounced and visibly swollen lymph node near collar bone on injection side; swelling persisted on  day 5, though pain faded after day 3. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of reported events. The clinical outcome of the events fatigue, insomnia ,lymph node pain and swollen lymph node was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: Pain in underarm (in the arm vaccine was administered); This is a spontaneous report from a non-contactable consumer, the parent. A 16-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm on 19Apr2021, as a single dose for COVID-19 immunisation. Medical history was reported as not applicable. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021, the patient experienced pain in underarm (in the arm where the vaccine was administered). The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain in underarm (in the arm where the vaccine was administered) was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Mass, Pain in extremity
Clinical narrative: Small lump in the area; Swollen lymph nodes; Left arm was sore; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 16Apr2021 at 10:45 (at the age of 70-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetic, heart condition and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included unspecified blood pressure medications from unknown date and unknown if ongoing. On 17Apr2021 at 07:00, the patient had a reaction to the vaccine which included swollen lymph nodes, a small lump in the area a day after the shot and the left arm was sore where the patient was vaccinated. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events small lump in the area, swollen lymph nodes and left arm was sore was resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Pain in extremity
Clinical narrative: Lymph node on my neck left side (same side as I got the vaccine) on top of the neck/arm soreness.; I have schedule a second appt to follow up on this lump; arm soreness.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0169) via an unspecified route of administration in the left arm on 16Apr2021 at 11:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first  dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via an unspecified route of administration in the left arm on 27Mar2021 at 11:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 14:00, the patient  went to urgent care and diagnosed with lymph node on her neck left side (same side that got the vaccine) on top of the neck/arm soreness. The patient reported that she written to saw whether this was a common side effect from the second vaccine. The patient was told to monitor the size and ensure that it was not painful, not red and to ensure the size reduced slowly. The patient scheduled a second appt to follow up on the lump. The adverse events resulted in emergency room/department or urgent care. The patient received treatment for the reported events which included cyclobenzaprine/naproxen. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lymph node on the neck left side (same side that got the vaccine) on top of the neck/arm soreness and lump was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Migraine; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 15Apr2021 at 09:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy (PCN). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified birth control medication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 25Mar2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 07:00, the patient had a 48-hour (as reported) migraine 5 days after the shot. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event which included a chiropractic adjustment. The clinical outcome of the event migraine was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Pain in extremity
Clinical narrative: Pain/tenderness in armpit and inside/underside of arm; Pain/tenderness in armpit and inside/underside of arm; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 09Apr2021 at 12:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety. The patient had known allergies to macadamia nuts and pineapple. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 14Apr2021 (also reported as five days post injection), the patient experienced pain/tenderness in armpit and inside/underside of arm which was lasting still twelve days post injection. The patient seemed to be improving. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of reported events. The clinical outcome of the events pain/tenderness in armpit and inside/underside of arm were resolved with sequelae (also reported as recovered with lasting effects) on 21Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Lymph node pain
Clinical narrative: Pain right where the lymph node located on the left side under the chin; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination and did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 11Mar2021 at 13:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. On 09Apr2021, the patient experienced pain right where the lymph node was located on the left side under the chin. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event pain right where the lymph node located on the left side under the chin was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Fatigue; Achy; This is a spontaneous report from a non-contactable consumer. An adult male patient of unspecified age received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Mar2021, as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, the patient experienced fatigue and achy. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue and achy were resolved on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: Fatigue; achy; headache; This is a spontaneous report from a non-contactable consumer. A non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Mar2021 as a single dose for COVID-19 immunisation. On an unknown date in Apr2021 the patient experienced fatigue, achy and headache. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fatigue, achy and headache was recovering at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Paresthesia in the immunized arm. A sensation of a "pricking" as if there was a plastic tab from a clothing sales tag poking into antecubital fossa repeatedly, but no foreign body identified.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ZR8727) via an unspecified route of administration in the left arm on 30Mar2021 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included hypercholesterolemia. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN) and tadalafil (CIALIS); both taken for unknown indications, from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 31Mar2021, the patient reported that for 2-4 days after he received the vaccine, he had a paraesthesia in the immunized arm. He had a "sensation of a pricking as if there was a plastic tab from a clothing sales tag poking into the antecubital fossa repeatedly, but no foreign body identified". It ultimately faded four days out and did not recur with the second dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination the patient had not been tested for COVID-19. The clinical outcome of the event "paraesthesia in the immunized arm, a sensation of a pricking as if there was a plastic tab from a clothing sales tag poking into the antecubital fossa repeatedly, but no foreign body identified" was resolved on 04Apr2021 after a duration of four days.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes
Clinical narrative: Large painful red cold sore on and under bottom lip. First time Ive had cold sore in the last 20years. Larger and redder than cold sores I had in the past. Larger today than yesterday Seems to be spreading across my lip.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 18Apr2021 at 14:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included essential tremor, cerebral palsy, depression and cold sores. The patient had no known allergies to medications, food, or other products. Concomitant medication taken within two weeks of vaccination were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021, the patient experienced large painful red cold sore on and under bottom lip. First time the patient had cold sore in the last 20years. Larger and redder than cold sores she had in the past. Larger on the day of report than previous day. Seemed to be spreading across her lip. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event large painful red cold sore on and under bottom lip, first time the patient had cold sore in the last 20years; larger and redder than cold sores she had in the past; larger on the day of report than previous day; seemed to be spreading across her lip was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Gingival pain, Hyperaesthesia teeth, Toothache
Clinical narrative: teeth sensitive; teeth hurt; gums hurt; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Medical history and concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 16:00, all of patient's teeth were sensitive and hurt and patient's gums hurt. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event teeth were sensitive, teeth hurt and gums hurt was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Facial pain, Facial paresis, Facial spasm, Muscle spasms
Clinical narrative: shooting pains in arms, legs, feets, hands; spasm  in arms, legs, feets, hands; Intermittent weakness in arms, legs, feets, hands; Shooting pains on face; Face spasm; Face weakness; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 13Apr2021 at 14:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included herpes simplex type 1 (HSV type 1), migraines, irritable bowel syndrome (IBS), headaches, post-traumatic stress disorder (PTSD) and tinnitus. Patient reported at Clinic for treatment as MC is too far( reported by patient). The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included acyclovir (MANUFACTURER UNKNOWN) from unknown date and for unspecified indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Mar2021 at 09:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 20:00 the patient experienced shooting pains, spasm, intermittent weakness in his arms, legs, feet's, hands and On unspecified date in Apr2021, the patient started to feel it on face. Comes and goes, started to become unbearable. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as the result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shooting pains, spasm, intermittent weakness in arms, legs, feet's, hands and on face were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: shooting pains in arms, legs, feets, hands; spasm  in arms, legs, feets, hands; Intermittent weakness in arms, legs, feets, hands; Shooting pains on face; Face spasm; Face weakness; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 13Apr2021 at 14:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included herpes simplex type 1 (HSV type 1), migraines, irritable bowel syndrome (IBS), headaches, post-traumatic stress disorder (PTSD) and tinnitus. Patient reported at Clinic for treatment as MC is too far( reported by patient). The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included acyclovir (MANUFACTURER UNKNOWN) from unknown date and for unspecified indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Mar2021 at 09:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 20:00 the patient experienced shooting pains, spasm, intermittent weakness in his arms, legs, feet's, hands and On unspecified date in Apr2021, the patient started to feel it on face. Comes and goes, started to become unbearable. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as the result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shooting pains, spasm, intermittent weakness in arms, legs, feet's, hands and on face were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea
Clinical narrative: Headache; Chills; nausea; This is a spontaneous report from a contactable consumer. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Apr2021 at 12:45 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. The patient did not have allergies to any medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included sertraline hydrochloride (ZOLOFT) from an unknown date, for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 30Mar2021 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 04:00, the patient experienced headache, nausea and chills. Therapeutic measures were taken as a result of the events headache, nausea, chills and included treatment with Tylenol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, nausea and chills were resolved on an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus in left ear; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8731) via an unspecified route of administration in the left arm on 16Apr2021 at 12:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications taken within two weeks of vaccination were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 12:45, the patient experienced tinnitus in left ear. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event tinnitus in left ear was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Vision is blurry; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 19Apr2021 at 12:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 22Mar2021 at 12:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 20Apr2021, the patient experienced blurry vision. She could not see herself clearly in the mirror, could not see well enough to drive, had to squint and put the laptop in front of eyes to see the screen. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event vision was blurry, could not see herself clearly in the mirror, could not see well enough to drive, had to squint and put the laptop in front of  eyes to see the screen was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy
Clinical narrative: Pain in left armpit.; Swollen lymph nodes; This is a spontaneous report from a contactable consumer. An adult female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 20Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, it was unknown if the patient diagnosed with COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the COVID vaccine. On 20Apr2021, post second dose of the Pfizer vaccination, the patient experienced pain in left armpit, probably from swollen lymph nodes. Since the vaccination, unknown if the patient had been tested for COVID-19. It was unknown if the patient received any treatment for the reported events. The clinical outcome of the events pain in left armpit and swollen lymph nodes was unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Myalgia, Nausea, Paraesthesia
Clinical narrative: Brain fog; Pins and needles feeling in lower legs and feet; Fatigue; Muscle aches; Nauseated; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 16Apr2021 at 15:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS) and anxiety. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. On 16Apr2021 at 17:00, the patient experienced brain fog, pins and needles feeling in lower legs and feet, fatigue, muscle aches and nauseated. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events brain fog, pins and needles feeling in lower legs and feet, fatigue, muscle aches and nauseated were resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pain
Clinical narrative: Bad headache; Really sore arm; Body aches; Chills; Slightly elevated temperature 99.6; Tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00(at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history.  The patient had allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 30Mar2021 at 09:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation.  Prior to  the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 17:00, the patient experienced really sore arm, body aches, chills, slightly elevated temperature 99.6 degrees, tiredness. On 21Apr2021, the next day, the patient experienced bad headache. The clinical outcome of the events really sore arm, body aches, chills, slightly elevated temperature 99.6 degrees, tiredness and bad headache the next day were resolved on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Bad headache; Really sore arm; Body aches; Chills; Slightly elevated temperature 99.6; Tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00(at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history.  The patient had allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 30Mar2021 at 09:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation.  Prior to  the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 17:00, the patient experienced really sore arm, body aches, chills, slightly elevated temperature 99.6 degrees, tiredness. On 21Apr2021, the next day, the patient experienced bad headache. The clinical outcome of the events really sore arm, body aches, chills, slightly elevated temperature 99.6 degrees, tiredness and bad headache the next day were resolved on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Left upper arm in agonizing, excruciating, throbbing pain..; Left upper arm in agonizing, excruciating, throbbing pain; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the left arm on 26Mar2021 at 15:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included polymyalgia rheumatica, rheumatoid arthritis, osteoporosis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medication included levothyroxine sodium (TIROSINT) from an unknown date for an unspecified indication. The patient previously took ibuprofen (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced drug allergy. On 27Mar2021 at 05:00, the patient woke at 05:00 the next morning of receiving vaccine, and experienced left upper arm in agonizing, excruciating, throbbing pain, lasted several hours. Pain got better, but did not leave, now 26 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left upper arm in agonizing, excruciating, throbbing pain, lasted several hours was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Dizziness, Headache, Neck pain
Clinical narrative: Neck pressure; Ache left side of back and lower left side; Slightly dizzy; Head ache left side of brain; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 09:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 15Apr2021 at 16:00, the patient experienced head ache on left side of the brain and neck pressure, ache on left side of back and lower left side and was still slightly dizzy at the time of report, but not as bad as on the first day. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events head ache left side of brain, neck pressure, ache left side of back and lower left side were recovered with sequelae (also reported as recovered with lasting effects) on an unknown date in Apr2021, while that of slightly dizzy was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Swelling near the right hand wrist. It is like a round bump; This is a spontaneous report from a contactable consumer. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW01U1) via an unspecified route of administration in the left arm on 15Apr2021 at 16:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and blood pressure high. It was not known if the patient had known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included thyroid (MANUFACTURER UNKNOWN), metoprolol succinate 50 (units unspecified) (METZOK) and cilnidipine (MANUFACTURER UNKNOWN); all from unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in left arm on 25Mar2021 at 16:45 (at the age of 52-years old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced swelling near the right hand wrist. It was like a round bump. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event swelling near the right hand wrist; it was like a round bump was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Dysgeusia, Insomnia, Paraesthesia
Clinical narrative: Tingling/burning sensation in hands, feet, and outside of legs,; Metallic taste in mouth; Insomnia; Tingling/burning sensation in hands, feet, and outside of legs; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Apr2021 at 12:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included hay fever. The patient did not have any allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 21Apr2021 at 12:30, the patient experienced insomnia, tingling/burning sensation in hands, feet and outside of legs and metallic taste in mouth. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events insomnia, tingling/burning sensation in hands, feet and outside of legs and metallic taste in mouth was not resolved at the time of the report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Musculoskeletal stiffness
Clinical narrative: Stiff neck, both sides; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an unspecified route of administration in the left arm on 08Feb2021 at 13:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and magnesium (MANUFACTURER UNKNOWN) and multivitamin, all for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the left arm on 14Jan2021 at 12:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Feb2021, the patient experienced stiff neck, both sides and headaches. These events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of stiff neck and headache and included treatment with Tylenol (MANUFACTURER UNKNOWN), heat and massage. The clinical outcome of the events stiff neck and headache were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenitis, Lymphadenopathy
Clinical narrative: Lymph node swelling; Lymph node swelling and infection three times; This is a spontaneous report from a contactable healthcare professional, the patient. A 55-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 16Feb2021 at 15:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had known allergies to sulfa. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 16Feb2021, the patient experienced lymph node swelling and infection three times. The events lymph node swelling and infection resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with unspecified antibiotics. The clinical outcome of the events lymph node swelling and infection was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes in neck; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 19Apr2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021, the patient experienced swollen lymph nodes in neck. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event swollen lymph nodes in neck was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.